The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 601–700 of 1,004
Munzar, P., Baumann, M. H., Shoaib, M. C., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050836 · Cited by 71
Reinforcing Effects of Nicotinic Compounds Intravenous Self-administration in Drug-Naive Mice
Rasmussen, T. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00003-3 · Cited by 71
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.2.190 · Cited by 70
Cocaine-induced hyperactivity and sensitization are dependent on GSK3
Miller, J. S., Tallarida, R. J., & Unterwald, E. M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.006 · Cited by 70
Differential Effects of Cocaine on Dopamine Neuron Firing in Awake and Anesthetized Rats
Koulchitsky, S., Backer, B. D., Quertemont, É., Charlier, C., & Seutin, V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.339 · Cited by 70
Hippocampal and amygdaloid interactions in the nucleus accumbens
Groenewegen, H. J., Mulder, A. B., Beijer, A. V. J., Wright, C. I., Lopes, F. H. D. S., & Pennartz, C. M. A. (1999) · Psychobiology · doi:10.3758/bf03332111 · Cited by 70
McGeehan, A., Janak, P. H., & Olive, M. F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1733-2 · Cited by 70
Modulation of Blood Pressure and Obesity With the Dopamine D2 Receptor GeneTaqI Polymorphism
Thomas, G. N., Tomlinson, B., & Critchley, J. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.177 · Cited by 70
Greenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.012 · Cited by 69
Self-citationPicciotto, M. R., Brabant, C., Einstein, E. B., Kamens, H. M., & Neugebauer, N. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.033 · Cited by 69
Morris, E. D., Yoder, K. K., Wang, C., Normandin, M. D., Zheng, Q., Mock, B. H., Raymond, F. M., & Froehlich, J. C. (2005) · Molecular Imaging · doi:10.2310/7290.2005.05130 · Cited by 69
de Haan, L., Lavalaye, J., van Bruggen, M., van Nimwegen, L. J. M., Booij, J., van Amelsvoort, T., & LINSZEN, D. H. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900503 · Cited by 69
Olausson, P., Engel, J. A., & Söderpalm, B. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00673-6 · Cited by 69
Carelli, R. M., & Deadwyler, S. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00442-x · Cited by 69
Dopaminergic Regulation of Striatal Interneurons in Reward and Addiction: Focus on Alcohol
Clarke, R. B. C., & Adermark, L. (2015) · Neural Plasticity · doi:10.1155/2015/814567 · Cited by 68
Drugs of Abuse and Brain Gene Expression
Torres, G., & Horowitz, J. M. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00007 · Cited by 68
Schildein, S., Ågmo, A., Huston, J. P., & Schwarting, R. K. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00062-6 · Cited by 68
Chen, J., Moratalla, R., Yu, L., Martín, A. B., Xu, K., Bastia, E., Hackett, E., Alberti, I., & Schwarzschild, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300152 · Cited by 68
Kim, J., Creekmore, E., & Vezina, P. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.10.001 · Cited by 67
Hao, Y., Yang, J., Guo, M., Wu, C. F., & Wu, M. F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.072 · Cited by 67
Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug Dependence
Hasebe, K., Kawai, K., Suzuki, T., Kawamura, K., Tanaka, T., Narita, M., Nagase, H., & Suzuki, T. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.050 · Cited by 67
Foll, B. L., Ciano, P. D., Panlilio, L. V., Goldberg, S. R., & Ciccocioppo, R. (2013) · Current Drug Targets · doi:10.2174/1389450111314070006 · Cited by 67
Couceyro, P. R., Evans, C. H., McKinzie, A. A., Mitchell, D., Dube, M., Hagshenas, L., White, F. J., Douglass, J., Richards, W. G., & Bannon, A. W. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091678 · Cited by 67
Zarrindast, M., Bahreini, T., & Adl, M. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00951-6 · Cited by 67
Rasmussen, D. D., Boldt, B. M., Wilkinson, C. W., & Mitton, D. R. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02572.x · Cited by 67
Chronic morphine and naltrexone fail to modify μ-opioid receptor mRNA levels in the rat brain
Castelli, M. P., Melis, M., Mameli, M., Fadda, P., Diaz, G., & GESSA, G. L. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00305-1 · Cited by 67
Riegel, A. C., Ali, S. F., & French, E. D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300193 · Cited by 67
Organization of the ophidian amygdala: Chemosensory pathways to the hypothalamus
Martínez-Marcos, A., Lanuza, E., & Halpern, M. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990913)412:1 · Cited by 45
Svingos, A. L., Clarke, C. L., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1 · Cited by 67
Riegel, A. C. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00062-8 · Cited by 66
Azizi, P., Haghparast, A., & Hassanpour-Ezatti, M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.009 · Cited by 66
Carelli, R. M., & Ijames, S. G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02217-4 · Cited by 66
Kolb, E. M., Rezende, E. L., Holness, L. F., Radtke, A., Lee, S. K., Obenaus, A., & Garland, T. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.076000 · Cited by 66
Kim, M.-R., Kim, S. J., Lyu, Y.-S., Kim, S., Lee, Y. K., Kim, T. H., Shim, I., Zhao, R., Golden, G. T., & Yang, C. H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.007 · Cited by 66
Feedback Control of Mesolimbic Somatodendritic Dopamine Release in Rat Brain
Rahman, S., & McBride, W. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740684.x · Cited by 66
Kindlundh, A. M. S., Lindblom, J., Bergström, L., & Nyberg, F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00120-9 · Cited by 66
Phillips, T. J., Wenger, C. D., & Dorow, J. D. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199706000-00021 · Cited by 66
Hasselmo, M. E., Wyble, B., & Wallenstein, G. V. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:6 · Cited by 366
Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons
Hunt, G. E., & McGregor, I. S. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00409-0 · Cited by 66
Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
Whiteaker, P., Garcha, H. S., Wonnacott, S., & Stolerman, I. P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16417.x · Cited by 66
Yu, P., An, S.-C., Tai, F., Zhang, X., He, F., Wang, J., An, X., & Wu, R. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.028 · Cited by 65
Involvement of the sigma1 receptor in the motivational effects of ethanol in mice
Maurice, T., Casalino, M., Lacroix, M., & Romieu, P. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00002-9 · Cited by 65
Mecamylamine and Ethanol Preference in Healthy Volunteers
Young, E. M., Mahler, S. V., Chi, H., & de Wit, H. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150007.34702.16 · Cited by 65
Caine, S. B., Humby, T., Robbins, T. W., & Everitt, B. J. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.4.880 · Cited by 65
(2010) · American journal of play · Cited by 65
Potential association of DRD2 and DAT1 genetic variation with heroin dependence
Hou, Q., & Li, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.004 · Cited by 64
Narita, M., Mizuo, K., Mizoguchi, H., Sakata, M., Narita, M., Tseng, L. F., & Suzuki, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01006.2003 · Cited by 64
Prenatal Morphine Enhances Morphine-Conditioned Place Preference in Adult Rats
Gagin, R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00281-5 · Cited by 64
Müller, C. P., Carey, R. J., Silva, M. A. D. S., Jocham, G., & Huston, J. P. (2002) · Synapse · doi:10.1002/syn.10083 · Cited by 64
Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine
Bespalov, A., Думпис, М. А., Piotrovsky, L. B., & Zvartau, E. E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00462-5 · Cited by 64
Spiga, S., Mulas, G., Piras, F., & Diana, M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00110 · Cited by 63
Kim, E., Quinn, J. G., Levine, A. S., & O‘Hare, E. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.001 · Cited by 63
A scale-free systems theory of motivation and addiction
Chambers, R. A., Bickel, W. K., & Potenza, M. N. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.005 · Cited by 63
Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis
Ornell, F. R., Hansen, F., Schuch, F. B., Rebelatto, F. P., Tavares, A. L. J., Scherer, J. N., Valério, A. G., Pechansky, F., Kessler, F. H. P., & DIEMEN, L. V. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.036 · Cited by 63
Park, Y. S., Sammartino, F., Young, N. A., Corrigan, J. D., Krishna, V., & Rezai, A. R. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.01.254 · Cited by 65
Narita, M., Matsushima, Y., Niikura, K., Narita, M., Takagi, S., Nakahara, K., Kurahashi, K., ABE, M., Saeki, M., Asato, M., et al. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00249.x · Cited by 63
Thornton, J. E., Loose, M. D., Kelly, M. J., & Rønnekleiv, O. K. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903410107 · Cited by 63
Narita, M., Aoki, T., & Suzuki, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00405-x · Cited by 63
Cowen, M. S., & Lawrence, A. J. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02326.x · Cited by 63
Bajo, M., Crawford, E. F., Roberto, M., Madamba, S. G., & Siggins, G. R. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20756 · Cited by 63
López‐Moreno, J. A., González‐Cuevas, G., de Fonseca, F. R., & Navarro, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2179-04.2004 · Cited by 63
ONE HUNDRED YEARS OF ALCOHOLISM: THE TWENTIETH CENTURY
Mann, K. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.1.10 · Cited by 63
Tanimura, A., Tojyo, Y., & Matsumoto, Y. (1993) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.62.15 · Cited by 63
Decreased Presynaptic Sensitivity to Adenosine after Cocaine Withdrawal
Manzoni, O. J., Pujalte, D., Williams, J. T., & Bockaert, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07996.1998 · Cited by 63
Heroin and its metabolites: relevance to heroin use disorder
Milella, M. S., D’Ottavio, G., Pirro, S. D., Barra, M., Caprioli, D., & Badiani, A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02406-5 · Cited by 62
Episodic Memories and Their Relevance for Psychoactive Drug Use and Addiction
Müller, C. P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00034 · Cited by 62
Kohno, M., Okita, K., Morales, A. M., Robertson, C. L., Dean, A. C., Ghahremani, D. G., Sabb, F. W., Rawson, R. A., Mandelkern, M. A., Bilder, R. M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.223 · Cited by 62
Role of exercise in the treatment of alcohol use disorders
Manthou, E., Georgakouli, K., Fatouros, I. G., Gianoulakis, C., Theodorakis, Y., & Jamurtas, A. Z. (2016) · Biomedical Reports · doi:10.3892/br.2016.626 · Cited by 62
Circuits, Drugs, and Drug Addiction
Koob, G. F. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60910-2 · Cited by 62
Self-citationCannabinoid-induced Fos expression within A10 dopaminergic neurons
Patel, S., & Hillard, C. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03797-6 · Cited by 62
Guo, Y., Wang, H., Xiang, X., & Zhao, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.005 · Cited by 62
Hart, C. L., Ward, A. S., Collins, E. D., Haney, M., & Foltin, R. W. (2003) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.015 · Cited by 62
Heinz, A., Sander, T., Harms, H., Finckh, U., Kühn, S., Dufeu, P., Dettling, M., Gräf, K., Rolfs, A., Rommelspacher, H., et al. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01954.x · Cited by 62
Cowen, M. S., Rezvani, A. H., Jarrott, B., & Lawrence, A. J. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04218.x · Cited by 62
Nicotine and Hippocampus-Dependent Learning: Implications for Addiction
Gould, T. J. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:2:93 · Cited by 61
Maxwell, A. L., Loxton, N. J., & Hennegan, J. M. (2016) · Appetite · doi:10.1016/j.appet.2016.12.037 · Cited by 61
Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
Leggio, G. M., Camillieri, G., Platania, C. B. M., Castorina, A., Marrazzo, G., Torrisi, S. A., Nona, C. N., D’Agata, V., Nóbrega, J. N., Stark, H., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.51 · Cited by 61
Leri, F., Zhou, Y., Goddard, B., Cummins, E., & Kreek, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300927 · Cited by 61
Li, X.-W., Li, T., & Froehlich, J. C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00191-7 · Cited by 61
Wang, X.-H., Levitt, P. R., Grayson, D. R., & Murphy, E. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00528-x · Cited by 61
The diagnostic dilemma of pathological appearance and performance enhancing drug use
Hildebrandt, T., Lai, J. K., Langenbucher, J. W., Schneider, M., Yehuda, R., & Pfaff, D. W. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.018 · Cited by 60
Kindlundh, A. M. S., Rahman, S., Lindblom, J., & Nyberg, F. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.040 · Cited by 60
Vathy, I., Šlamberová, R., Rimanóczy, Á., Riley, M. A., & Bar, N. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00355-x · Cited by 60
Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence
Heinz, A., Goldman, D. A., Gallinat, J., Schumann, G., & Puls, I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1903-x · Cited by 60
GABAA receptors in the basolateral amygdala are involved in mediating morphine reward
Zarrindast, M., Ahmadi, S., Haeri-Rohani, A., Rezayof, A., Jafari, M. R., & Jafari‐Sabet, M. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.048 · Cited by 60
5‐HT Receptor Knockout Mice: Pharmacological Tools or Models of Psychiatric Disorders
Scearce-Levie, K. A., CHEN, J. ‐., Gardner, E. L., & Hen, R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11350.x · Cited by 60
Influence of Cocaine on the JAK–STAT Pathway in the Mesolimbic Dopamine System
Berhow, M. T., Hiroi, N., Kobierski, L. A., Hyman, S. E., & Nestler, E. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08019.1996 · Cited by 60
Hyytiä, P., Bäckström, P., & Liljequist, S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00446-x · Cited by 60
Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor ε1 subunit
Miyamoto, Y., Yamada, K., Nagai, T., Mori, H., Mishina, M., Furukawa, H., Noda, Y., & Nabeshima, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03086.x · Cited by 60
Kelley, B. M., & Rowan, J. D. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.04.002 · Cited by 59
Blanchard, B. A., & Glick, S. D. (2002) · Springer eBooks · doi:10.1007/0-306-47138-8_15 · Cited by 59
Jiao, H., Zhang, L., Gao, F., Lou, D., Zhang, J., & Xu, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04840.x · Cited by 59
Zuo, L., Kranzler, H. R., Luο, X., Yang, B., Weiss, R. D., Brady, K. T., Poling, J. C., Farrer, L. A., & Gelernter, J. E. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.206 · Cited by 59
Theberge, F. R. M., Pickens, C. L., Goldart, E. M., Fanous, S., Hope, B. T., Liu, Q., & Shaham, Y. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2784-z · Cited by 59
Mok, E. Y.-M., & Munro, A. D. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00038-9 · Cited by 59
Effects of haloperidol in a response-reinstatement model of heroin relapse
Ettenberg, A., MacConell, L., & Geist, T. D. (1996) · Psychopharmacology · doi:10.1007/bf02246658 · Cited by 59
Dextromethorphan reduces intravenous cocaine self-administration in the rat
Pulvirenti, L., Balducci, C., & Koob, G. F. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00970-3 · Cited by 59
Self-citationSchmidt, B. L., Tambeli, C. H., Levine, J. D., & Gear, R. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01915.x · Cited by 59
Reward-quality dependent anticipation in rat nucleus accumbens
Miyazaki, K., Mogi, E., Araki, N., & Matsumoto, G. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00032 · Cited by 59
Tanabe, J., Regner, M. F., Sakai, J. T., Martínez, D., & Gowin, J. L. (2019) · British Journal of Radiology · doi:10.1259/bjr.20180942 · Cited by 58
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review